Open AccessFirst clinical experience of the use of ustekinumab (Stelara) for treatment of psoriatic patients in Russia
Author(s) -
L F ZNAMENSKAYA,
Svetlana I. Svishchenko
Publication year - 2012
Publication title -
vestnik dermatologii i venerologii
Language(s) - English
Resource type - Journals
eISSN - 2313-6294
pISSN - 0042-4609
DOI - 10.25208/vdv667
Subject(s) - ustekinumab , medicine , psoriasis , interleukin 23 , dermatology , psoriasis area and severity index , clinical efficacy , interleukin , disease , cytokine , infliximab
The authors examined the efficacy and safety of treatment of patients suffering from moderate to severe forms of psoriasis with ustekinumab (blocker of р40 subunit of interleukin-12 and interleukin-23) taking into account the PASi index. They revealed high clinical efficacy of ustekinumab for treatment of psoriatic patients.